Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 18 | 18 | 18 | 18 | 18 |
| Cost of Goods | 2 | 2 | 2 | 2 | 2 |
| Gross Profit | 17 | 17 | 17 | 17 | 17 |
| Operating Expenses | 1,021 | 898 | 1,182 | 791 | 1,133 |
| Operating Income | -1,003 | -880 | -1,164 | -773 | -1,115 |
| Interest Expense | 2 | 2 | 0 | 1 | 2 |
| Other Income | 73 | 80 | 112 | 114 | 104 |
| Pre-tax Income | -932 | -802 | -1,052 | -660 | -1,013 |
| Net Income Continuous | -932 | -802 | -1,052 | -660 | -1,013 |
| Net Income | $-932 | $-802 | $-1,121 | $-660 | $-1,013 |
| EPS Basic Total Ops | -0.31 | -0.28 | -0.38 | -0.21 | -0.32 |
| EPS Basic Continuous Ops | -0.31 | -0.28 | -0.36 | -0.21 | -0.32 |
| EPS Diluted Total Ops | -0.31 | -0.28 | -0.38 | -0.21 | -0.32 |
| EPS Diluted Continuous Ops | -0.31 | -0.28 | -0.36 | -0.21 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.28 | N/A | N/A | N/A |
| EBITDA(a) | $-1,003 | $-880 | $-1,164 | $-751 | $-1,081 |